Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 3, Number 1, January 1992   [Index by Author] 
Other Issues: Previous Next  

Down In this issue
Down Contents of the next issue
Down NEWS
Down Editorials
Down Special articles
Down Review
Down Arena
Down Original articles
Down Book reviews
Down Short reports
Down Letters
Down Instructions to Authors


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

In this issue Back

In this issue
Ann Oncol 1992 3: 1. [PDF] [Request Permissions]  

Contents of the next issue Back

Contents of the next issue
Ann Oncol 1992 3: 1. [PDF] [Request Permissions]  

NEWS Back

First Horten Prize to Doll and Peto
Ann Oncol 1992 3: 2. [PDF] [Request Permissions]  

Steven Dickman
Clinical cancer research: Cancer treatment from the ‘Red Baron’ Dresden
Ann Oncol 1992 3: 2-4. [PDF] [Request Permissions]  

Free enterprise, nurses and ethical problems in Maastricht
Ann Oncol 1992 3: 4-5. [PDF] [Request Permissions]  

Europeans still undecided on chemoprevention for breast cancer
Ann Oncol 1992 3: 5-6. [PDF] [Request Permissions]  

Underground production of cytotoxic drugs?
Ann Oncol 1992 3: 6. [PDF] [Request Permissions]  

ESMO Award Lecture coupled with Oliva Prize
Ann Oncol 1992 3: 6. [PDF] [Request Permissions]  

Perhaps not everyone knows that...
Ann Oncol 1992 3: 6-7. [PDF] [Request Permissions]  

Editorials Back

F. Cavalli
The Annals continues to grow
Ann Oncol 1992 3: 8. [PDF] [Request Permissions]  

K. Østerlind and H. H. Hansen
Ways to a better treatment of small cell lung cancer—a commentary
Ann Oncol 1992 3: 9-10. [PDF] [Request Permissions]  

Special articles Back

J.-C. Cerottini, V. von Fliedner, and T. Boon
Recognition of tumor-associated antigens by T lymphocytes: From basic concepts to new approaches
Ann Oncol 1992 3: 11-16. [PDF] [Request Permissions]  

Review Back

J. P. Neijt
Treatment of advanced ovarian cancer: 10 years of experience
Ann Oncol 1992 3: 17-27. [Abstract] [PDF] [Request Permissions]  

Arena Back

B. A. Stoll
Does extra height justify a higher risk of breast cancer?
Ann Oncol 1992 3: 29-30. [Abstract] [PDF] [Request Permissions]  

Original articles Back

E. Alba, J. J. Breton, L. Alonso, G. Paredes, J. Belon, and P. Ballesteros
Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs
Ann Oncol 1992 3: 31-35. [Abstract] [PDF] [Request Permissions]  

C. F. Krommer and J. P. Szalai
Cyclophosphamide, Adriamycin and Cisplatin (CAP) versus Cyclophosphamide, Adriamycin and Vincristin (CAV) in the treatment of advanced ovarian cancer: A randomized study
Ann Oncol 1992 3: 37-39. [Abstract] [PDF] [Request Permissions]  

P. P. B. James and G. M. Mead
Sanctuary site relapse in chemotherapy-treated testicular cancer
Ann Oncol 1992 3: 41-43. [Abstract] [PDF] [Request Permissions]  

S. M. Ansell, G. Falkson, R. van der Merwe, and A. Uys
Chronological age is a multifactorial prognostic variable in patients with Non-Hodgkin's Lymphoma
Ann Oncol 1992 3: 45-50. [Abstract] [PDF] [Request Permissions]  

M. Soesan, A. Paccagnella, V. Chiarion-Sileni, L. Salvagno, A. Fornasiero, G. Sotti, P.-L. Zorat, A. Favaretto, and M. Fiorentino
Extramedullary plasmacytoma: Clinical behaviour and response to treatment
Ann Oncol 1992 3: 51-57. [Abstract] [PDF] [Request Permissions]  

B. Leyland-Jones, B. R. Davies, K. Clagett-Carr, D. Shoemaker, D. Macfarlane, C. Fortner, P. J. O'Dwyer, G. Sarosy, B. J. Foster, H. G. Chun, D. E. Hoth, and L. V. Rubinstein
Patient treatment on a compassionate basis: Documentation of high adverse drug reaction rate
Ann Oncol 1992 3: 59-62. [Abstract] [PDF] [Request Permissions]  

G. Toffoli, S. Frustaci, L. Tumiotto, R. Talamini, F. Gherlinzoni, P. Picci, and M. Boiocchi
Expression of MDR1 and GST-{pi} in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness
Ann Oncol 1992 3: 63-69. [Abstract] [PDF] [Request Permissions]  

L. Damstrup, J. Andersen, D. W. Kufe, D. F. Hayes, and H. Skovgaard Poulsen
Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor
Ann Oncol 1992 3: 71-77. [Abstract] [PDF] [Request Permissions]  

Book reviews Back

N. de Tribolet
Book review
Ann Oncol 1992 3: 40. [PDF] [Request Permissions]  

A. Pedrazzini
Book review
Ann Oncol 1992 3: 44. [PDF] [Request Permissions]  

C. Sessa
Book review
Ann Oncol 1992 3: 58. [PDF] [Request Permissions]  

C. Bosia
Book reviews
Ann Oncol 1992 3: 70. [PDF] [Request Permissions]  

Short reports Back

E. E. Vokes, D. J. Haraf, J. M. McEvilly, R. Mick, M. F. Kozloff, M. D. Goldman, W. J. Moran, N. J. Clendeninn, M. A. Collier, R. R. Weich selbaum, and W. R. Panje
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach
Ann Oncol 1992 3: 79-81. [Abstract] [PDF] [Request Permissions]  

B. Weinerman, E. Eisenhauer, D. Stewart, W. Mertens, I. Tannock, P. Venner, and R. Spaulding
Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer
Ann Oncol 1992 3: 83-84. [PDF] [Request Permissions]  

N. A. Pavlidis, E. Briassoulis, G. Klouvas, and M. Bai
Is interferon-a an active agent in Castleman's disease?
Ann Oncol 1992 3: 85-86. [PDF] [Request Permissions]  

Letters Back

A. Martoni, A. Cricca, M. Guaraldi, M. Covizzi, A. Farris, and F. Pannuti
Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer
Ann Oncol 1992 3: 87-88. [PDF] [Request Permissions]  

A. Thyss, M. H. Gaspard, R. Marsault, G. Milano, C. Frelin, and M. Schneider
Very high endothelin plasma levels in patients with 5-FU cardiotoxicity
Ann Oncol 1992 3: 88. [PDF] [Request Permissions]  

Instructions to Authors Back

Instructions to Authors
Ann Oncol 1992 3: 89-90. [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.